Logo image of SGBX

SAFE & GREEN HOLDINGS CORP (SGBX) Stock Fundamental Analysis

NASDAQ:SGBX - Nasdaq - US78418A6047 - Common Stock - Currency: USD

0.8037  -0.04 (-4.57%)

After market: 0.7953 -0.01 (-1.05%)

Fundamental Rating

0

Taking everything into account, SGBX scores 0 out of 10 in our fundamental rating. SGBX was compared to 52 industry peers in the Construction & Engineering industry. SGBX may be in some trouble as it scores bad on both profitability and health. SGBX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SGBX had negative earnings in the past year.
In the past year SGBX has reported a negative cash flow from operations.
SGBX had negative earnings in each of the past 5 years.
In the past 5 years SGBX always reported negative operating cash flow.
SGBX Yearly Net Income VS EBIT VS OCF VS FCFSGBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

Looking at the Return On Assets, with a value of -383.03%, SGBX is doing worse than 92.31% of the companies in the same industry.
Industry RankSector Rank
ROA -383.03%
ROE N/A
ROIC N/A
ROA(3y)-187.65%
ROA(5y)-122.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGBX Yearly ROA, ROE, ROICSGBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

SGBX's Gross Margin of 2.15% is on the low side compared to the rest of the industry. SGBX is outperformed by 80.77% of its industry peers.
The Profit Margin and Operating Margin are not available for SGBX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGBX Yearly Profit, Operating, Gross MarginsSGBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

SGBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SGBX has been increased compared to 1 year ago.
The number of shares outstanding for SGBX has been increased compared to 5 years ago.
SGBX has a worse debt/assets ratio than last year.
SGBX Yearly Shares OutstandingSGBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
SGBX Yearly Total Debt VS Total AssetsSGBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

SGBX has an Altman-Z score of -30.67. This is a bad value and indicates that SGBX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -30.67, SGBX is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -30.67
ROIC/WACCN/A
WACC17.13%
SGBX Yearly LT Debt VS Equity VS FCFSGBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.08 indicates that SGBX may have some problems paying its short term obligations.
SGBX has a worse Current ratio (0.08) than 92.31% of its industry peers.
SGBX has a Quick Ratio of 0.08. This is a bad value and indicates that SGBX is not financially healthy enough and could expect problems in meeting its short term obligations.
SGBX has a worse Quick ratio (0.05) than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.05
SGBX Yearly Current Assets VS Current LiabilitesSGBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.77% over the past year.
Looking at the last year, SGBX shows a very negative growth in Revenue. The Revenue has decreased by -63.72% in the last year.
Measured over the past years, SGBX shows a quite strong growth in Revenue. The Revenue has been growing by 10.76% on average per year.
EPS 1Y (TTM)62.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.83%
Revenue 1Y (TTM)-63.72%
Revenue growth 3Y-49.37%
Revenue growth 5Y10.76%
Sales Q2Q%-46.65%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y27.82%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year39.31%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SGBX Yearly Revenue VS EstimatesSGBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
SGBX Yearly EPS VS EstimatesSGBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGBX. In the last year negative earnings were reported.
Also next year SGBX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGBX Price Earnings VS Forward Price EarningsSGBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGBX Per share dataSGBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SGBX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFE & GREEN HOLDINGS CORP

NASDAQ:SGBX (6/10/2025, 8:08:04 PM)

After market: 0.7953 -0.01 (-1.05%)

0.8037

-0.04 (-4.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-05 2025-05-05
Earnings (Next)08-12 2025-08-12
Inst Owners3.31%
Inst Owner Change-37.8%
Ins Owners8.94%
Ins Owner Change0%
Market Cap5.14M
Analysts82.86
Price TargetN/A
Short Float %30.29%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-91.59%
Min Revenue beat(2)-94.08%
Max Revenue beat(2)-89.09%
Revenue beat(4)0
Avg Revenue beat(4)-90.18%
Min Revenue beat(4)-94.08%
Max Revenue beat(4)-85.14%
Revenue beat(8)0
Avg Revenue beat(8)-67.02%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.86
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-12.11
EYN/A
EPS(NY)-0.98
Fwd EYN/A
FCF(TTM)-1.74
FCFYN/A
OCF(TTM)-1.72
OCFYN/A
SpS0.94
BVpS-2.02
TBVpS-2.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -383.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.15%
FCFM N/A
ROA(3y)-187.65%
ROA(5y)-122.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.19%
Cap/Sales 1.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.05
Altman-Z -30.67
F-Score3
WACC17.13%
ROIC/WACCN/A
Cap/Depr(3y)218.94%
Cap/Depr(5y)483.55%
Cap/Sales(3y)6.13%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.83%
EPS Next Y27.82%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-63.72%
Revenue growth 3Y-49.37%
Revenue growth 5Y10.76%
Sales Q2Q%-46.65%
Revenue Next Year39.31%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.02%
OCF growth 3YN/A
OCF growth 5YN/A